Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fried

Showing results (291-300 of 383) with videos related to

Pageof 39
Sort By:
Gut|October 10, 2015
Hepatitis C virus treatment in the real world: optimising treatment and access to therapiesFabien Zoulim, T Jake Liang, Alexander L Gerbes, et al.
Hepatitis Research and Treatment|October 25, 2012
Hepatitis C virus: a critical appraisal of new approaches to therapyDavid R Nelson, Donald M Jensen, Mark S Sulkowski, et al.
The American Journal of Gastroenterology|November 1, 1993
A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis BA M Di Bisceglie, T L Fong, M W Fried, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 8, 2015
Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemiaXavier Forns, Fred Poordad, Marcos Pedrosa, et al.
Open Forum Infectious Diseases|May 30, 2019
Prevalence and Impact of Hepatitis E Virus Infection Among Persons With Chronic Hepatitis B Living in the US and CanadaDavid R McGivern, Hsing-Hua S Lin, Junyao Wang, et al.
Hepatology (Baltimore, Md.)|September 26, 2002
Hepatitis C in adults and adolescents with hemophilia: a randomized, controlled trial of interferon alfa-2b and ribavirinMichael W Fried, Joy Peter, Keith Hoots, et al.
Hepatology (Baltimore, Md.)|January 29, 2008
HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis BMichael W Fried, Teerha Piratvisuth, George K K Lau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2020
Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 (COVID-19) Hospitalized Across the United StatesMichael W Fried, Julie M Crawford, Andrea R Mospan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2020
Reply to Roussel et alMichael W Fried, Julie M Crawford, Andrea R Mospan, et al.
Hepatology (Baltimore, Md.)|September 1, 1992
A pilot study of ribavirin therapy for chronic hepatitis CA M Di Bisceglie, M Shindo, T L Fong, et al.
Pageof 39

Showing results (291-300 of 383) with videos related to

Sort By:
Pageof 39
Gut|October 10, 2015
Hepatitis C virus treatment in the real world: optimising treatment and access to therapiesFabien Zoulim, T Jake Liang, Alexander L Gerbes, et al.
Hepatitis Research and Treatment|October 25, 2012
Hepatitis C virus: a critical appraisal of new approaches to therapyDavid R Nelson, Donald M Jensen, Mark S Sulkowski, et al.
The American Journal of Gastroenterology|November 1, 1993
A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis BA M Di Bisceglie, T L Fong, M W Fried, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 8, 2015
Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemiaXavier Forns, Fred Poordad, Marcos Pedrosa, et al.
Open Forum Infectious Diseases|May 30, 2019
Prevalence and Impact of Hepatitis E Virus Infection Among Persons With Chronic Hepatitis B Living in the US and CanadaDavid R McGivern, Hsing-Hua S Lin, Junyao Wang, et al.
Hepatology (Baltimore, Md.)|September 26, 2002
Hepatitis C in adults and adolescents with hemophilia: a randomized, controlled trial of interferon alfa-2b and ribavirinMichael W Fried, Joy Peter, Keith Hoots, et al.
Hepatology (Baltimore, Md.)|January 29, 2008
HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis BMichael W Fried, Teerha Piratvisuth, George K K Lau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2020
Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 (COVID-19) Hospitalized Across the United StatesMichael W Fried, Julie M Crawford, Andrea R Mospan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2020
Reply to Roussel et alMichael W Fried, Julie M Crawford, Andrea R Mospan, et al.
Hepatology (Baltimore, Md.)|September 1, 1992
A pilot study of ribavirin therapy for chronic hepatitis CA M Di Bisceglie, M Shindo, T L Fong, et al.
Pageof 39